课题基金 / 基金详情

项目摘要

项目成果

JOEL K. ELMQUIST的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The increasing incidence of obesity is a major health issue facing the USA. Moreover, the mechanisms underlying anorexia nervosa remain poorly understood. Fortunately, in the past decade several key hormones and CMS pathways controlling body weight and glucose homeostasis have been identified. Indeed, we now have a rough CNS roadmap through which key metabolic signals like leptin exert its effects which may lead to effective strategies to combat the incidence of obesity and eating disorders. In the past grant period, we sought to delineate the neural substrates through which melanocortin 4 receptors (MC4-Rs) selectively regulate food intake, body weight and glucose homeostasis. We focused on the potential interactions of leptin-regulated neuronal systems and MC4-R systems. Collectively, our data suggests that different sites in the brain mediate different effects of MC4-R agonists to regulate body weight, food intake, and glucose homeostasis. Specifically, we found that neurons in the paraventricular nucleus of the hypothalamus regulate food intake, but do not regulate energy expenditure. In the current proposal, we will extend these observations using our mouse model in which we can selectively reactivate MC4-R expression. We will identify if neurons in the raphe pallidus are sufficient to regulate energy expenditure. We will also determine if reactivation of MC4-Rs in autonomic preganglionic neurons is sufficient to rescue the reduced energy expenditure and diabetes characteristic of MC4-R deficiency. Finally, we will determine is MC4-R expression by autonomic preganglionic neurons is required for normal body weight and glucose homeostasis by selectively deleting MC4-Rs in autonomic preganglionic neurons in mice that express MC4-Rs everywhere else in the brain.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pilot and Feasibility Program
  • 批准号:
    10657791
  • 项目类别:
  • 资助金额:
    $20.5万
  • 财政年份:
    2022
  • 负责人:
    JOEL K. ELMQUIST
  • 依托单位:
Pilot and Feasibility Program
  • 批准号:
    10512737
  • 项目类别:
  • 资助金额:
    $20.5万
  • 财政年份:
    2022
  • 负责人:
    JOEL K. ELMQUIST
  • 依托单位:
Leptin Reduction as a Potent Mitigative Strategy for the Treatment of PASC
  • 批准号:
    10554019
  • 项目类别:
  • 资助金额:
    $79.16万
  • 财政年份:
    2021
  • 负责人:
    JOEL K. ELMQUIST
  • 依托单位:
Metabolic Benefits of Leptin Reduction
  • 批准号:
    10621237
  • 项目类别:
  • 资助金额:
    $67.08万
  • 财政年份:
    2021
  • 负责人:
    JOEL K. ELMQUIST
  • 依托单位:
海外基金